How much funding has Damae Medical raised?

Damae Medical has raised $27.8M in total funding, most recently a Seed round.

Who are Damae Medical's investors?

Damae Medical's investors include Unknown, Creadev, Partech, Kurma Partners, BNP Paribas Développement.

When was Damae Medical founded?

Damae Medical was founded in 2014.

Where is Damae Medical headquartered?

Damae Medical is headquartered in Paris, France.

What industry is Damae Medical in?

Damae Medical operates in Biotech, Healthcare.

How many employees does Damae Medical have?

Damae Medical has 11-50 employees.

Damae Medical

Paris, France · Founded 2014 · $27.8M raised

Biotech

Healthcare

Headquarters: Paris
Employees: 11–50
Founded: 2014
Business Model: B2B

Website: damae-medical.com
Total Funding: $27.8M
Last Round: $5.7M SeedNov 2025
Rounds: 3

About

Damae Medical is a Paris-based medtech company founded in 2014 as a spin-off from the University of Paris-Saclay, specializing in non-invasive skin imaging for cancer detection. The company developed deepLive™, a handheld medical imaging device based on LC-OCT (Line-field Confocal Optical Coherence Tomography) technology that provides 3D cellular-resolution imaging of skin tissue in vivo, enabling dermatologists to perform digital biopsies without cutting. deepLive™ received CE Mark Class IIA under EU MDR in 2023 and FDA 510(k) clearance in March 2025, and has been deployed in over 10 countries across Europe, Japan, Australia, and the United States. The company has raised over €27M including a €15M Series B in 2025 led by Creadev.

Summary

Damae Medical is a Biotech company based in Paris, France, founded in 2014. It has raised $27.8M in total across 3 rounds, most recently a $5.7M Seed round in Nov 2025. Investors include Unknown, Creadev and Partech.